Literature DB >> 17419252

Epidemiology of hepatocellular carcinoma in lower Egypt, Mansoura Gastroenterology Center.

Mohamed Abdel-Wahab1, N El-Ghawalby, M Mostafa, A Sultan, M El-Sadany, O Fathy, T Salah, F Ezzat.   

Abstract

BACKGROUND/AIMS: Hepatocellular carcinoma (HCC) is now regarded as one of the major malignant diseases worldwide, with significant variations in its epidemiology.
OBJECTIVE: study of the epidemiology of hepatocellular carcinoma and its relation to age, sex, residence, and viral hepatitis in Egypt.
METHODOLOGY: From January 1992 to May 2005, 1012 cases with hepatocellular carcinoma were diagnosed in the Gastroenterology Center, Mansoura University, Egypt. All patients were evaluated for age, sex, residence, occupation, history of other medical disease, anti-bilharzial treatment, blood transfusion, viral markers, and liver functions.
RESULTS: The mean age was 54.26 +/- 9.2, with high prevalence between 51 and 60 years. Male to female ratio was 5:1, farmers constituted 37.6%, workers 22.9% and housewives 12.8% of the patients. The number of HCC patients increases yearly from only 9 patients evaluated at 1992 to 80 patients in the first 5 months of the year 2005. The mean age increased from 45 years at 1992 up to 58 years at year 1996. Seventy-seven percent of the patients were resident in rural areas versus 23% in urban areas. Seventy-eight percent of patients presented with abdominal pain, 7.1% with abdominal swelling, 4.3% with jaundice, 2.4% with other symptoms and 8.8% of the HCCs were discovered accidentally. The prevalence of diabetes mellitus among HCC patients was 13.6%, history of anti-bilharzial treatment was positive in 37.6%. Hepatitis C, B and mixed B&C was 76.6%, 3.3%, 3.6% respectively. History of blood transfusion was encountered in only 10.6%. Twenty-seven percent of HCC patients had previous history of surgery. Clinical and laboratory studies revealed that, 52.1% of patients were Child's A, 37.3% B and 10.7% C. Tumor size >5 cm in 65.5%, the right lobe was the site in 63.9%, left lobe in 25.8% and both lobes in 10.3% of the patients. Lesions were single in 71.1%, multiple in 24.9% and diffuse in 4% of cases. Portal vein thrombosis was detected in 15.9%. Hepatic resection was done in 25.8%, chemoembolizations in 17.2%, radiofrequency in 13.1%, alcohol injection in 0.9%, mixed treatment in 3.5% of patients while 38.7% were managed by conservative treatment due to no available safe treatment.
CONCLUSIONS: The number of newly diagnosed patients with HCC increases annually. The prevalence of HCC is high in Nile Delta area, and is more common in males, rural residents and farmers especially in HCV patients. In rural areas there are other risk factors that may be responsible for this high incidence, such as pollution, aflatoxins and use of insecticides, which need more study.

Entities:  

Mesh:

Year:  2007        PMID: 17419252

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  13 in total

1.  Epidemiologic risk factors of hepatocellular carcinoma in a rural region of Egypt.

Authors:  Amr S Soliman; Chu-Wei Hung; Alexander Tsodikov; Ibrahim A Seifeldin; Mohamed Ramadan; Dina Al-Gamal; Emily L Schiefelbein; Priyanka Thummalapally; Subhojit Dey; Kadry Ismail
Journal:  Hepatol Int       Date:  2010-08-19       Impact factor: 6.047

2.  Significance of Glypican-3 in Early Detection of Hepatocellular Carcinoma in Cirrhotic Patients.

Authors:  Ahmed M Tahon; Magdy Z El-Ghanam; Samy Zaky; Tarek Mostafa Emran; Ali M Bersy; Fathiya El-Raey; Elsayed A Z; Amr M El Kharsawy; Dina Johar
Journal:  J Gastrointest Cancer       Date:  2019-09

3.  Recent insights on risk factors of hepatocellular carcinoma.

Authors:  Nabil Mohie Abdel-Hamid
Journal:  World J Hepatol       Date:  2009-10-31

4.  Human Schistosomiasis mansoni associated with hepatocellular carcinoma in Egypt: current perspective.

Authors:  Manar Mahmoud El-Tonsy; Hesham Mohammed Hussein; Thanaa El-Sayed Helal; Rania Ayman Tawfik; Khalid Mohamed Koriem; Hend Mohamed Hussein
Journal:  J Parasit Dis       Date:  2014-12-20

5.  Global geographical overlap of aflatoxin and hepatitis C: controlling risk factors for liver cancer worldwide.

Authors:  D L Palliyaguru; F Wu
Journal:  Food Addit Contam Part A Chem Anal Control Expo Risk Assess       Date:  2013-01-02

6.  Treatment of portal vein tumor thrombus of hepatocellular carcinoma with percutaneous laser ablation.

Authors:  Zheng-Hua Lu; Feng Shen; Zhen-Lin Yan; Jun Li; Jia-He Yang; Ming Zong; Le-Hua Shi; Meng-Chao Wu
Journal:  J Cancer Res Clin Oncol       Date:  2008-11-26       Impact factor: 4.553

7.  Cancer pain management in resource-limited settings: a practice review.

Authors:  Elizabeth Namukwaya; Mhoira Leng; Julia Downing; Elly Katabira
Journal:  Pain Res Treat       Date:  2011-12-11

8.  Serum microRNA 143 and microRNA 215 as potential biomarkers for the diagnosis of chronic hepatitis and hepatocellular carcinoma.

Authors:  Zhu-qing Zhang; Hua Meng; Nan Wang; Li-na Liang; Li-na Liu; Shu-ming Lu; Yong Luan
Journal:  Diagn Pathol       Date:  2014-07-02       Impact factor: 2.644

Review 9.  Hepatocellular carcinoma in the world and the middle East.

Authors:  H Poustchi; Sg Sepanlou; S Esmaili; N Mehrabi; A Ansarymoghadam
Journal:  Middle East J Dig Dis       Date:  2010-01

Review 10.  Relative Importance of Hepatitis B and C Viruses in Hepatocellular Carcinoma in EMRO Countries and the Middle East: A Systematic Review.

Authors:  Seyed Moayed Alavian; Hossein Haghbin
Journal:  Hepat Mon       Date:  2016-03-06       Impact factor: 0.660

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.